Radiation Therapy for Heart Rhythm Disorder: A Safer Alternative
- Here's a summary of the news article, broken down into key points:
- * radiation Therapy as an Alternative to Catheter Ablation: The study suggests that radiation therapy may be a comparable, and potentially safer, alternative to repeat catheter ablation for...
- * American Society for Radiation Oncology (ASTRO) Annual Meeting: The findings were presented at this meeting.
Here’s a summary of the news article, broken down into key points:
* radiation Therapy as an Alternative to Catheter Ablation: The study suggests that radiation therapy may be a comparable, and potentially safer, alternative to repeat catheter ablation for patients with severe, medication-resistant ventricular tachycardia (VT).
* First Direct Comparison: this is the first study to directly compare cardiac radiation to standard catheter ablation for VT.
* Fewer Complications with Radiation: Patients receiving radiation therapy experienced considerably fewer serious complications requiring hospitalization (9% vs. 38% in the ablation group) within a year of treatment. Complications also occured sooner after ablation.
* Similar Effectiveness: The study found similar effectiveness in controlling the disease between the two treatment methods.
* What is VT? Ventricular tachycardia is a perilous heart rhythm disturbance linked to significant health problems and mortality. Patients often rely on strong medications, defibrillators, and frequent hospitalizations.
* Refractory VT is the Focus: The study focused on patients with refractory or end-stage VT – meaning their condition doesn’t respond to medication or initial ablation attempts, and they are at high risk from further invasive procedures.
* How Radiation Works (STAR): Stereotactic arrhythmia radiation therapy (STAR) uses precisely targeted radiation beams to eliminate the scarred tissue causing the abnormal rhythm,avoiding the need for invasive catheters and anesthesia.
* Study Details: The retrospective analysis included 43 patients (22 radiation, 21 ablation) with high-risk refractory VT. Most had already undergone at least one ablation procedure.
Where to find more information:
* American Society for Radiation Oncology (ASTRO) Annual Meeting: The findings were presented at this meeting.
* international Journal of Radiation Oncology • Biology • Physics (Red Journal): The study will be published in this journal.
* ENCORE-VT trial: Previous research by the same team showed positive results with cardiac radiation.